| Low Molecular Weight Heparin or no Treatment Following Cesarean Delivery (NCT06118957) | University of Utah | 2023-10-11 |
| ETHAN - ET for Male BC (NCT05501704) | Jose Pablo Leone | 2023-10-11 |
| HER2 Targeted HypoSti.CAR-T Cells in HER2 Positive Advanced Solid Tumors (NCT05681650) | Chinese PLA General Hospital | 2023-10-11 |
| Efficacy and Safety of AK104 Combined With Chemotherapy and Recombinant Human Adenovirus 5 Injection in Cervical Cancer (NCT06455046) | Fujian Cancer Hospital | 2023-10-11 |
| Study of TROP2 CAR Engineered IL15-transduced Cord Blood-derived NK Cells Delivered Intraperitoneally for the Management of Platinum Resistant Ovarian Cancer, Mesonephric-like Adenocarcinoma, and Pancreatic Cancer (NCT05922930) | M.D. Anderson Cancer Center | 2023-10-11 |
| Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of SAR442501 in Pediatric Participants With Achondroplasia (NCT06067425) | Sanofi | 2023-10-10 |
| Comparison of the Efficacy and Safety of Duloxetine Augmented With Gabapentin and Duloxetine Augmented With Amitriptyline vs Duloxetine Alone in Chemotherapy -Induced Neuropathy (NCT06091553) | Beni-Suef University | 2023-10-10 |
| Relationship Between Abnormal Myocardial Perfusion and Diastolic Dysfunction in Sickle Cell Disease Using PET (NCT05583721) | St. Jude Children's Research Hospital | 2023-10-10 |
| Phase 2 Study of AFM13 in Combination With AB-101 in Subjects With R/R HL and CD30+ PTCL (NCT05883449) | Affimed GmbH | 2023-10-10 |
| PARP Inhibitor CVL218 in Combination Therapy for Patients With Advanced Solid Tumors (NCT06078670) | Fujian Cancer Hospital | 2023-10-10 |
| A Study to Investigate Ompenaclid Combined With FOLFIRI Plus Bevacizumab in Advanced/Metastatic Colorectal Cancer (NCT05983367) | Inspirna, Inc. | 2023-10-10 |
| Efficacy Analysis of Neoadjuvant Treatment in Lung Cancer Using Low-dose Nivolumab Combined With Chemotherapy (NCT06667154) | Aline Fusco Fares, MD | 2023-10-10 |
| A Novel Combination Therapeutic Strategy Aiming to Functional Cure for Chronic Hepatitis B Virus Infection (Sustained HBsAg Loss) (B) (NCT05771402) | The Second Affiliated Hospital of Chongqing Medical University | 2023-10-10 |
| A Novel Combination Therapeutic Strategy Aiming to Functional Cure for Chronic Hepatitis B Virus Infection (Sustained HBsAg Loss) (A) (NCT05769816) | The Second Affiliated Hospital of Chongqing Medical University | 2023-10-10 |
| A Phase 2 Study of Ivosidenib in Previously Treated Japanese Subjects With Nonresectable or Metastatic Cholangiocarcinoma With an IDH1 Mutation (NCT06081829) | Servier | 2023-10-10 |
| Combining ICI With SBRT or HypoFrx-RT for ES NSCLC (NCT05451173) | Alexander Chi | 2023-10-09 |
| Safety, Tolerability and Antidepressant Effects of DMT in Patients With Depression (NCT06094907) | Universidade Federal do Rio Grande do Norte | 2023-10-09 |
| Insomnia Treatment and EMA (Ecological Momentary Assessment) Outcomes (NCT05908526) | University of Maryland, Baltimore | 2023-10-09 |
| A Phase II Clinical Trial to Evaluate the Immunogenicity and Safety of SARS-CoV-2 Bivalent mRNA Vaccine (LVRNA021) (NCT05939648) | AIM Vaccine Co., Ltd. | 2023-10-09 |
| A Study of Samuraciclib and Elacestrant in Participants With Metastatic or Locally Advanced HR+/HER2-negative Breast Cancer (NCT05963997) | Carrick Therapeutics Limited | 2023-10-09 |
| Immunogenicity and Safety of Comvigen (Bivalent) Vaccine (NCT05930730) | Chulalongkorn University | 2023-10-09 |
| A Study to Evaluate INCB099280 in Participants With Advanced Cutaneous Squamous Cell Carcinoma (NCT05888844) | Incyte Corporation | 2023-10-09 |
| A Study of JNJ-77242113 in Participants With Moderately to Severely Active Ulcerative Colitis (NCT06049017) | Janssen Research & Development, LLC | 2023-10-09 |
| Zimberelimab Combined With Albumin-bound Paclitaxel and Cisplatin in Neoadjuvant Treatment of LACC (NCT06055738) | Tang-Du Hospital | 2023-10-09 |
| Dexamethasone at Night vs at Induction on PONV After Laparoscopic Cholecystectomy (NCT05998317) | Mansoura University | 2023-10-08 |
| The Efficacy and Safty of FMT in Patients With CID (NCT05917379) | Peking University Sixth Hospital | 2023-10-08 |
| YN001 in Healthy Subjects and Patients With Coronary Atherosclerosis (NCT06048588) | Beijing Inno Medicine Co., Ltd. | 2023-10-08 |
| Antiperistaltic Effect and Safety of Glycopyrronium for Colonoscopic Polypectomy (NCT06041984) | Jie Chen | 2023-10-08 |
| A Study to Evaluate Mesenchymal Stem Cell Product StromaForte's Effect on Cardiovascular Events (NCT06087848) | Cellcolabs Clinical LTD. | 2023-10-07 |
| Study of Hepalatide in Chronic Hepatitis D(CHD) Patients (NCT05827146) | Shanghai HEP Pharmaceutical Co., Ltd. | 2023-10-07 |
| OCTANE: Adjuvant Liposomal Doxorubicin and Carboplatin for Early-stage Triple-negative Breast Cancer (NCT05949021) | Mridula George, MD | 2023-10-07 |
| Durvalumab With Consolidative Radiochemotherapy and Ablative Stereotactic Radiotherapy in Oligometastatic ES-SCLC (NCT06223711) | Universität des Saarlandes | 2023-10-06 |
| 5-Day Preoperative Radiation for Soft Tissue Sarcoma (NCT06087861) | Stanford University | 2023-10-06 |
| Tirabrutinib Maintenance Versus Placebo in Patients With Primary CNS Lymphoma in Complete Remission (JCOG2104) (NCT06940791) | Kyorin University | 2023-10-06 |
| A Study to Investigate Vaccine Responses in Subcutaneous Amlitelimab Treated Atopic Dermatitis Participants Aged 18 Years and Older Compared With Placebo (NCT06015308) | Sanofi | 2023-10-06 |
| TRADE: Dose Escalation Tolerability of Abemaciclib in HR+ HER2- Early Stage Breast Cancer (NCT06001762) | Dana-Farber Cancer Institute | 2023-10-05 |
| Phase 2B Safety and Efficacy Study of VGT-309 in Subjects With Cancer in the Lung. (NCT06145048) | Vergent Bioscience, Inc. | 2023-10-05 |
| A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors (NCT05941507) | LigaChem Biosciences, Inc. | 2023-10-05 |
| Tislelizumab Plus Concurrent Chemoradiation in Older With ESCC (NCT06061146) | Tianjin Medical University Cancer Institute and Hospital | 2023-10-05 |
| Tislelizumab (One Anti-PD-1 Antibody) Plus Low-dose Bevacizumab for Bevacizumab Refractory Recurrent Glioblastoma (NCT05540275) | Henan Provincial People's Hospital | 2023-10-05 |
| Diagnostic Accuracy Study for OWL-EVO1 as a Lung Cancer EVOC® Probe (Evolution Phase 2) (NCT06193239) | Owlstone Ltd | 2023-10-05 |
| Therapeutic Strategies for Microvascular Dysfunction in Type 1 Diabetes (NCT05478707) | AdventHealth Translational Research Institute | 2023-10-05 |
| Sing For Your Saunter Part 2 R33 (NCT06115382) | Washington University School of Medicine | 2023-10-05 |
| Assessment of PF614 Effects on Experimental Pain in the Cold Pressure Test (PF614-201) (NCT06629402) | Ensysce Biosciences | 2023-10-05 |
| TQB3909 Tablets in Subjects With Relapsed or Refractory Mantle Cell Lymphoma (MCL) (NCT06106841) | Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. | 2023-10-05 |
| A Novel Obesity Prevention Program for High-Risk Infants in Primary Care (NCT06028113) | Children's Hospital Medical Center, Cincinnati | 2023-10-05 |
| A Study of LY3556050 in Adult Participants With Diabetic Peripheral Neuropathic Pain (NCT06074562) | Eli Lilly and Company | 2023-10-05 |
| Azacitidine Combined With Venetoclax in Patients With Higher-risk Chronic Myelomonocytic Leukemia (AVENHIR) (NCT05768711) | Groupe Francophone des Myelodysplasies | 2023-10-04 |
| Phase I/II Study of JR-441 in Patients With Mucopolysaccharidosis Type IIIA (NCT06095388) | JCR Pharmaceuticals Co., Ltd. | 2023-10-04 |
| Difluoromethylornithine and High Dose Testosterone With Enzalutamide in Metastatic Castration-Resistant Prostate Cancer (NCT06059118) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2023-10-04 |
| Open Label PK, PD and DDI of Dotinurad and Allopurinol in Gout Patients With Hyperuricemia (NCT06056570) | Urica Therapeutics Inc. | 2023-10-04 |
| NMDA Receptor Modulation for the Treatment of Bipolar I Disorder (NCT05977023) | China Medical University Hospital | 2023-10-04 |
| A Study of TRK-950 When Used in Combination With Ramucirumab and Paclitaxel in Patients With Gastric Cancer (NCT06038578) | Toray Industries, Inc | 2023-10-04 |
| Polatuzumab Vedotin (Pola) Plus Rituximab (R) in Patients With Post-transplant Lymphoproliferative Disorder (PTLD) (NCT06040320) | Washington University School of Medicine | 2023-10-04 |
| Cannabidiol in the Treatment of Opioid Use Disorder (NCT06206291) | Yasmin Hurd | 2023-10-04 |
| Central Nervous System Efficacy of Capmatinib in NSCLC With Brain Metastases With cfDNA Positive MET Alterations (NCT05567055) | Timothy Burns, MD, PHD | 2023-10-03 |
| Leflunomide or Combination of MEK Inhibitor and Hydroxychloroquine for Refractory Patients With RAS Mutations (NCT06229340) | N.N. Petrov National Medical Research Center of Oncology | 2023-10-03 |
| Baricitinib in the Treatment of Adults With Pyoderma Gangrenosum (PG) (NCT04901325) | Oregon Health and Science University | 2023-10-03 |
| Pulsed Dose Chemotherapy Plus Pembrolizumab in Recurrent/Metastatic HNSCC (NCT06052839) | Dan Zandberg | 2023-10-03 |
| An Evaluation of Maintenance Therapy Combination Mirvetuximab Soravtansine and Olaparib (NCT05887609) | University of Colorado, Denver | 2023-10-03 |
| Circulating Tumor DNA to Guide Changes in Standard of Care Chemotherapy (NCT05770531) | Vanderbilt-Ingram Cancer Center | 2023-10-03 |
| Cannabis Consumption and Driving Impairment Assessment on a Closed Course (NCT06059677) | Bayliss J. Camp, PhD | 2023-10-03 |
| Dose, Safety, and Pathogenicity of a New Influenza B Strain (NCT06254820) | Hvivo | 2023-10-03 |
| Mezigdomide Plus Ixazomib and Dexamethasone for Relapsed and Refractory Multiple Myeloma (NCT06050512) | Kathleen Dorritie | 2023-10-02 |
| Study of Chemosensory Enhancement Through Neuromodulation Training (SCENT for Long COVID) (NCT05855369) | Medical University of South Carolina | 2023-10-02 |
| Metastatic Castrate-Resistant Prostate Cancer Subjects Treated With PROVENGE® + One Infusion of Sipuleucel-T (NCT06134232) | Dendreon | 2023-10-02 |
| Safety, Efficacy, and Pharmacokinetics of Continuous Subcutaneous Lenalidomide in Multiple Myeloma (MM) (NCT06087653) | Starton Therapeutics, Inc | 2023-10-02 |
| Pharmacokinetic and Safety Study of Oral Lofexidine in Neonates Experiencing Opioid Withdrawal Due to Intrauterine Exposure to Opioids (NCT06047834) | BioCorRx Pharmaceuticals Inc | 2023-10-02 |
| Short Contact Protocols to Reduce Pain During 10% ALA Gel Red-light Photodynamic Therapy of Actinic Keratoses (NCT06027619) | Case Comprehensive Cancer Center | 2023-10-02 |
| PrEPsmart 2-1-1 Pilot (NCT06631365) | Public Health Foundation Enterprises, Inc. | 2023-10-02 |
| Passive Antibodies Against COVID-19 With EVUSHELD in Vaccine Non-responsive CLL (NCT05465876) | Sunnybrook Health Sciences Centre | 2023-10-01 |
| Efficacy of Letermovir in Preventing Cytomegalovirus (CMV) Infection in Lung Transplant Recipients vs. Valganciclovir. (NCT06057194) | Maimónides Biomedical Research Institute of Córdoba | 2023-10-01 |
| COlchicine iN Circulating Inflammatory Markers After StrokE (CONCISE) (NCT06062277) | University College Dublin | 2023-10-01 |
| BC3402 in Combination With Durvalumab in Patients With Advanced Hepatocellular Carcinoma (NCT06111326) | Biocity Biopharmaceutics Co., Ltd. | 2023-10-01 |
| Blinatumomab Prevents Recurrence of R/R ALL After Allo-HSCT (NCT06075238) | Sichuan University | 2023-10-01 |
| A Dose Escalation Study of Intensity Modulated Total Marrow Irradiation (IMRT-TMI) Followed by Fludarabine as a Myeloablative Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Relapsed and Refractory Hematologic Malignancies (NCT05201183) | Naoyuki G. Saito, M.D., Ph.D. | 2023-10-01 |
| An Open Label Phase II Study of First-Line Maintenance Enzalutamide Following Docetaxel Plus Androgen-Deprivation Therapy in Patients With Previously-Untreated, Metastatic, Castration-Naive Prostatic Adenocarcinoma (NCT06015321) | Samsung Medical Center | 2023-10-01 |
| Intralesional Acyclovir Versus Cryotherapy in the Treatment of Plantar Warts. A Randomized Controlled Trial. (NCT06261684) | Cairo University | 2023-10-01 |
| Surufatinib Combined With Toripalimab and AG Regiments for First-line Treatment of Unresectable or Relapsing Metastatic Ampullary Carcinoma (NCT06062485) | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | 2023-10-01 |
| Apabetalone for Pulmonary Arterial Hypertension (NCT04915300) | Laval University | 2023-10-01 |
| Tofacitinib Associated With Meglumine Antimoniate in Cutaneous Leishmaniasis (NCT06011343) | Hospital Universitário Professor Edgard Santos | 2023-10-01 |
| Efficacy and Safety of CD19CD20-CAR.p40-T in B-cell Lymphoma (NCT07097207) | Shenzhen University General Hospital | 2023-10-01 |
| Nimotuzumab Plus Tislelizumab for Recurrent and Metastatic Cervical Cancer (NCT06039891) | Peking Union Medical College Hospital | 2023-10-01 |
| Investigating the Efficacy of Autologous, Adipose-derived Mesenchymal Stem Cell Therapy for the Treatment of Sexual Function Impairment in Women Aged 40-50 (NCT06726538) | Vinmec Research Institute of Stem Cell and Gene Technology | 2023-10-01 |
| Augmented Reality for Orthognatic Surgery Patient Education (NCT06140043) | University Medical Center Groningen | 2023-10-01 |
| Gemox Combined With Anlotinib and Sintilimab in Advanced cHCC-ICC (NCT06033118) | Sichuan University | 2023-10-01 |
| HEM-iSMART-A: Decitabine / Venetoclax and Navitoclax in Pediatric Patients With Relapsed or Refractory Hematological Malignancies (NCT05740449) | Princess Maxima Center for Pediatric Oncology | 2023-10-01 |
| An Efficacy and Safety Study of AVR-RD-02 Compared to Enzyme Replacement Therapy for Treatment of Gaucher Disease Type 3 (NCT05815004) | AVROBIO | 2023-10-01 |
| COVID-19 ThromboprophylaXIs Study of Novel FXIa Inhibitor Frunexian (EP-7041) in ICU Patients (NCT05040776) | eXIthera Pharmaceuticals | 2023-10-01 |
| Tirelizumab Combined With Chemotherapy in the Treatment of HER-2 Negative Locally Advanced Gastric Cancer (NCT06284746) | Lin Chen | 2023-10-01 |
| Pianzumab Combined With AVD Regimen in the Treatment of Newly-diagnosed Advanced Classic Hodgkin Lymphoma (NCT05949931) | Sun Yat-sen University | 2023-10-01 |
| A Trial of HRF2105 Patch in Relieving Pain of Osteoarthritis (NCT06047483) | Jiangsu HengRui Medicine Co., Ltd. | 2023-10-01 |
| A Study of QLS31905 Combination Chemotherapy as First-Line Treatment in Patients With Advanced Solid Tumors (NCT06041035) | Qilu Pharmaceutical Co., Ltd. | 2023-10-01 |
| 68Ga-P16-093 PET/CT Imaging in the Salivary Gland (NCT06049368) | Peking Union Medical College Hospital | 2023-10-01 |
| A-RGEMOX in the Treatment of Early Relapsed/Refractory DLBCL (NCT06086197) | Zhejiang Cancer Hospital | 2023-10-01 |
| A Study to Observe and Evaluate the Safety and Efficacy of c610 Injection for Treatment of Advanced Solid Tumor Patients (NCT06082570) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2023-10-01 |
| Exploratory Dose Ranging Study Assessing APH-1501 for the Treatment of Opioid Addiction (NCT03813095) | Aphios | 2023-10-01 |
| A Study to Observe and Evaluate the Safety and Efficacy of T60c Injection for Treatment of Advanced Solid Tumor Patients (NCT06082557) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2023-10-01 |
| Methylprednisolone in Patients With Cognitive Deficits in Post-COVID-19 Syndrome (PCS) (NCT05986422) | Charite University, Berlin, Germany | 2023-10-01 |
| 1% Acetic Acid vs Normal Saline Dressing inManagement of Diabetic Foot (NCT06356480) | Dr. Muhammad Naeem | 2023-10-01 |